Skip to main content
. 2021 Jun 7;9:675606. doi: 10.3389/fped.2021.675606

Table 2.

Primary and secondary outcome measures.

Outcome bLf group (n = 75) Placebo group (n = 75) Odds ratio (95% CI) Relative risk (95% CI)
Primary, n (%)
Antibiotic-associated diarrhea 16 (21.3) 7 (9.3) 2.6 (1.02–6.8) 2.29 (0.89–5.88)
Secondary, n (%)
Intravenous rehydration 0 1 (1.28)
Discontinuation of antibiotic treatment 0 0

bLf, bovine lactoferrin.